Status:
UNKNOWN
COVID-19 Post-Vaccination Observation
Lead Sponsor:
Yang I. Pachankis, PhD
Conditions:
Immune System Diseases
COVID-19 Vaccine Adverse Reaction
Eligibility:
All Genders
18-70 years
Brief Summary
The study started after the second COVID-19 vaccination of the participant with blood spots appearing on the skin with severe arthritis. The study continued to the third-dose full vaccination of the p...
Eligibility Criteria
Inclusion
- All COVID-19 vaccinated are eligible for inclusion.
Exclusion
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 24 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT06107348
Start Date
July 1 2021
End Date
December 24 2023
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Residential Address
Chongqing, Chongqing Municipality, China, 402762